Another MOR activator, oxycodone, revealed its favourable impact on EMT-related markers in human breast cancer SKBR3 cells; however, only E- and N-cadherin levels were determined and found to be upregulated and downregulated, respectively (Table 2). This evidence concerns the gene CDH2 and breast carcinoma.